ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes

Marco Racioppi, Emilio Sacco, Pierfrancesco Bassi, Mauro Ragonese, Giuseppe Palermo

Research output: Contribution to journal › Article

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes'. Together they form a unique fingerprint.

Medicine & Life Sciences